Cargando…

Establishing Molecular Subgroups of CD8+ T Cell-Associated Genes in the Ovarian Cancer Tumour Microenvironment and Predicting the Immunotherapy Response

Background: The mechanism by which infiltrating CD8+ T lymphocytes in the tumour microenvironment influence the survival of patients with ovarian cancer (OC) remains unclear. Methods: To identify biomarkers to optimise OC treatment, 13 immune-cell-line-associated datasets, RNA sequencing data, and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yunshu, Liang, Leilei, Li, Jian, Zeng, Jia, Yao, Hongwen, Wu, Lingying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525231/ https://www.ncbi.nlm.nih.gov/pubmed/37760841 http://dx.doi.org/10.3390/biomedicines11092399

Ejemplares similares

Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression
por: Li, Jian, et al.
Publicado: (2022)

ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription
por: Liang, Leilei, et al.
Publicado: (2022)

Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer
por: Liang, Leilei, et al.
Publicado: (2022)

Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model
por: Liang, Leilei, et al.
Publicado: (2021)

CD8(+) Tumour-Infiltrating Lymphocytes and Tumour Microenvironment Immune Types as Biomarkers for Immunotherapy in Sinonasal Intestinal-Type Adenocarcinoma
por: García-Marín, Rocío, et al.
Publicado: (2020)

Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment
por: Johnson, Racheal Louise, et al.
Publicado: (2021)

Knowing the tumour microenvironment to optimise immunotherapy
por: MERLANO, M.C., et al.
Publicado: (2019)

Tumour microenvironment‐based molecular profiling reveals ideal candidates for high‐grade serous ovarian cancer immunotherapy
por: Lu, Xiaofan, et al.
Publicado: (2021)

Current status, challenges and perspectives: immunotherapy and tumour microenvironment in thoracic cancer
por: Luo, Peng, et al.
Publicado: (2020)

Quantitative histology analysis of the ovarian tumour microenvironment
por: Lan, Chunyan, et al.
Publicado: (2015)

Using macrophage activation to augment immunotherapy of established tumours
por: Fridlender, Z G, et al.
Publicado: (2013)

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
por: Colton, Madyson, et al.
Publicado: (2020)

Tissue-specific tumour microenvironments are an emerging determinant of immunotherapy responses
por: Oliver, Amanda J., et al.
Publicado: (2020)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
por: Zhang, Xuehua, et al.
Publicado: (2022)

Tumour-reactive T cell subsets in the microenvironment of ovarian cancer
por: Westergaard, Marie Christine Wulff, et al.
Publicado: (2019)

Immunohistochemical profiling of the tumour microenvironment in borderline and malignant ovarian tumours in young women
por: O'Neill, Danielle, et al.
Publicado: (2023)

Establishment of a tumor immune microenvironment-based molecular classification system of breast cancer for immunotherapy
por: Zheng, Xiaobo, et al.
Publicado: (2021)

Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment
por: Chen, Yang, et al.
Publicado: (2022)

Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities
por: Linares, Christian A., et al.
Publicado: (2023)

CD8(+) T cell–Dependent Remodeling of the Tumor Microenvironment Overcomes Chemoresistance
por: Lao, Liyan, et al.
Publicado: (2023)

Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment
por: Barbolina, Maria V., et al.
Publicado: (2011)

The peritoneal tumour microenvironment of high-grade serous ovarian cancer
por: Leinster, D Andrew, et al.
Publicado: (2012)

Correction: Tumour-reactive T cell subsets in the microenvironment of ovarian cancer
por: Westergaard, Marie Christine Wulff, et al.
Publicado: (2019)

The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy
por: Wo, Yu Jun, et al.
Publicado: (2019)

Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma
por: Cheung, Chun Chau Lawrence, et al.
Publicado: (2023)

CXCR6 by increasing retention of memory CD8(+) T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer
por: Muthuswamy, Ravikumar, et al.
Publicado: (2021)

Suppression of established hepatocarcinoma in adjuvant only immunotherapy: alum triggers anti-tumor CD8(+) T cell response
por: Wang, Bo, et al.
Publicado: (2015)

Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy
por: Han, Zhi-Jian, et al.
Publicado: (2021)

The establishment and application of CD3E humanized mice in immunotherapy
por: Zhang, Rufeng, et al.
Publicado: (2022)

The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
por: Rodriguez, Galaxia M., et al.
Publicado: (2018)

The Role of TIM-3 and LAG-3 in the Microenvironment and Immunotherapy of Ovarian Cancer
por: Kozłowski, Mateusz, et al.
Publicado: (2022)

Fates of CD8+ T cells in Tumor Microenvironment
por: Maimela, Nomathamsanqa Resegofetse, et al.
Publicado: (2018)

Directing the Future Breakthroughs in Immunotherapy: The Importance of a Holistic Approach to the Tumour Microenvironment
por: Newnes, Hannah V., et al.
Publicado: (2021)

Unravelling Tumour Microenvironment in Melanoma at Single-Cell Level and Challenges to Checkpoint Immunotherapy
por: Bai, Xinyu, et al.
Publicado: (2022)

The role of caspase-8 in the tumor microenvironment of ovarian cancer
por: Kostova, Izabela, et al.
Publicado: (2020)

Role of Exosomal Non-Coding RNA in the Tumour Microenvironment of Genitourinary System Tumours
por: Wu, Shuang, et al.
Publicado: (2023)

Characterization of tumour microenvironment reprogramming reveals invasion in epithelial ovarian carcinoma
por: Zhang, Yuanfu, et al.
Publicado: (2023)

Synergy between CD8 T Cells and Th1 or Th2 Polarised CD4 T Cells for Adoptive Immunotherapy of Brain Tumours
por: Hoepner, Sabine, et al.
Publicado: (2013)

Replicating viral vector platform exploits alarmin signals for potent CD8(+) T cell-mediated tumour immunotherapy
por: Kallert, Sandra M., et al.
Publicado: (2017)

The combined signatures of the tumour microenvironment and nucleotide metabolism-related genes provide a prognostic and therapeutic biomarker for gastric cancer
por: Liu, Jifeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ph154s3phsgk5aicnmriejl88b